An update on xylazine in the unregulated drug supply: Harms and public health responses in Canada and the United States
This Bulletin updates recent data on xylazine’s presence in the unregulated drug supply from a CCENDU alert in July 2022. It also assesses concerns among community partners and highlights public health-based solutions.
Published by
Canadian Centre on Substance Use and Addiction
Date
Language(s)
English, French
Audience
Service provider resources
Resource Type
Report